Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies
- PMID: 29643233
- DOI: 10.1126/scitranslmed.aap9630
Hematopoietic stem cell transplantation in its 60s: A platform for cellular therapies (V体育官网)
Abstract
Over the last 60 years, more than a million patients received hematopoietic cell transplantation. Having incorporated multiple changes in clinical practices, it remains a complex procedure facing a dual challenge: cure of the underlying disease and prevention of relapse while controlling potentially severe complications. Improved understanding of underlying biological processes resulted in the design of innovative therapies engineered from defined cell populations and testing of these therapies as addition or substitution at virtually every step of the procedure. This review provides an overview of these developments, many of them now applied outside the historical field of hematopoietic cell transplantation VSports手机版. .
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U. S. Government Works V体育安卓版. .
Publication types
MeSH terms
- Actions (V体育2025版)
- Actions (V体育官网)
VSports最新版本 - LinkOut - more resources
Full Text Sources
"VSports最新版本" Other Literature Sources